Search -

Displaying 61 - 80 of 357

Sort: Relevancy | Date

Presentation TCT 2024

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

Presenter: Radoslaw Parma

October 28, 2024

Presentation TCT 2024

The Redo TAVR App: A Comprehensive Diagnosis, Procedure Planning, and Training Tool

Presenter: Vinayak Bapat

October 28, 2024

Presentation TCT 2024

Projecting the Frequency of Failed Transcatheter Aortic Valves

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

TCT 952: Identification and Analysis of Commissural Fibrosis of Bioprosthetic Heart Valve Explants: A Novel Mechanism of Bioprosthetic Stenosis

Presenter: Hacina Gill

October 28, 2024

Presentation TCT 2024

TCT 119: Long-Term Incidence and Predictors of Transcatheter vs Surgical Bioprosthetic Pulmonary Valve Failure

Presenter: Revathy Sampath-Kumar

October 28, 2024

Presentation TCT 2024

TCT 1562: Snaring Technique as a Method to Deploy Bioprosthetic Transcatheter Aortic Valve (TAVR) Across a Native Bicuspid Valve With Atypical Leaflet Fusion

Presenter: Khyati Khattar

October 28, 2024

Presentation TCT 2024

TCT 86: Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves: A Propensity-Matched Analysis

Presenter: Tiberio Frisoli

October 27, 2024

Presentation TCT 2024

TCT 88: Bioprosthetic Valve Fracture After Valve-in-Valve Transcatheter Mitral Valve Replacement Improves Transcatheter Heart Valve Expansion

Presenter: Akshay Kamath

October 27, 2024

Presentation TCT 2024

TCT 924: Valve in Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 27, 2024

Presentation TCT 2024

TCT 760: Valve In Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Meta-Analysis of Echocardiographic and Long-Term Outcomes

Presenter: Kyriakos Dimitriadis

October 27, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

ViV TMVR in a Patient With Torrential Bioprosthetic MR in Cardiogenic Shock

Presenter: Chloe Kharsa

June 07, 2024

Presentation NY Valves 2024

Halt is Not Relevant

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Halt is Relevant

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Presenter: David A. Wood

June 06, 2024

Presentation NY Valves 2024

Debate Con

Presenter: Amr E. Abbas

June 06, 2024

Presentation NY Valves 2024

Debate Pro

Presenter: Howard C. Herrmann

June 06, 2024

Advertisement

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

The Redo TAVR App: A Comprehensive Diagnosis, Procedure Planning, and Training Tool

Projecting the Frequency of Failed Transcatheter Aortic Valves

TCT 952: Identification and Analysis of Commissural Fibrosis of Bioprosthetic Heart Valve Explants: A Novel Mechanism of Bioprosthetic Stenosis

TCT 119: Long-Term Incidence and Predictors of Transcatheter vs Surgical Bioprosthetic Pulmonary Valve Failure

TCT 1562: Snaring Technique as a Method to Deploy Bioprosthetic Transcatheter Aortic Valve (TAVR) Across a Native Bicuspid Valve With Atypical Leaflet Fusion

TCT 86: Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves: A Propensity-Matched Analysis

TCT 88: Bioprosthetic Valve Fracture After Valve-in-Valve Transcatheter Mitral Valve Replacement Improves Transcatheter Heart Valve Expansion

TCT 924: Valve in Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Systematic Review and Meta-Analysis

TCT 760: Valve In Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Meta-Analysis of Echocardiographic and Long-Term Outcomes

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

ViV TMVR in a Patient With Torrential Bioprosthetic MR in Cardiogenic Shock

Halt is Not Relevant

Halt is Relevant

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Debate Con

Debate Pro

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content